Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
63 Results for "
PD-L1 monoclonal antibody
" in MedChemExpress (MCE) Product Catalog:
Products (63)
63 Results for "PD-L1 monoclonal antibody" in MCE Product Catalog:
42
42 Publications Verification
Cat. No.: HY-P9904
CAS No.: 1380723-44-3
Synonyms: MPDL3280A; RG-7446; RO-5541267
Target:
Research Areas:
11
11 Cited Publications
Cat. No.: HY-108730
CAS No.: 1537032-82-8
Synonyms: Anti-Human PD-L1, Human antibody; MSB 0010718C; MSB0010718C
Target:
Research Areas:
11
11 Cited Publications
Target:
Research Areas:
7
Target:
Research Areas:
7
Target:
Research Areas:
5
5 Cited Publications
Cat. No.: HY-P990679
Target:
Research Areas:
5
Target:
Research Areas:
3
Target:
Research Areas:
3
Target:
Research Areas:
Tislelizumab is a monoclonal antibody that specifically binds to programmed cell death receptor 1 (PD-1), blocking its interaction with programmed death ligand 1 (PD-L1) and programmed death ligand 2 (PD-L2). Tislelizumab can reactivate immune cells such as T lymphocytes and enhance anti-tumor activity. Tislelizumab can be used for the research of a variety of tumors including typical Hodgkin's lymphoma, urothelial carcinoma, non-small cell lung cancer and hepatocellular carcinoma .
1
1 Cited Publications
Cat. No.: HY-P990114
Target:
Research Areas:
Cat. No.: HY-P9997
CAS No.: 2412764-40-8
Synonyms: ANB030
Target:
Research Areas:
Cat. No.: HY-P9978
CAS No.: 1924598-82-2
Synonyms: JS-001; TAB-001; Tripleitriumab; CHS-007; Teriprizumab; Treprizumab
Target:
Research Areas:
Toripalimab is a selective, recombinant, humanized monoclonal antibody against PD-1. Toripalimab is able to bind to PD-1 and block the interaction with its ligands. Toripalimab has exhibited primary anti-tumor effects in tumors such as melanoma, lung cancer, digestive tract tumors, hepatobiliary and pancreatic tumors, neuroendocrine neoplasms, nasopharyngeal carcinoma and urothelial carcinoma .
Cat. No.: HY-177439
Research Areas:
HLX43 is an antibody-drug conjugate (ADC) targeting PD-L1. HLX43 consists of a human monoclonal antibody anti-PD-L1 antibody Opucolimab (HY-P99785) with the drug-linker conjugate being DL-01 (HY-155870A). HLX43 exerts superior anticancer efficacy with safety profile in vivo. HLX43 can be used for non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), esophageal squamous cell carcinoma (ESCC), melanoma (MEL), ovarian cancer (Ovc) research .
Cat. No.: HY-P99422
CAS No.: 2247114-85-6
Synonyms: SHR-1316
Target:
Research Areas:
Cat. No.: HY-P99489
CAS No.: 2098225-93-3
Synonyms: ABBV 181; PR 1648817
Target:
Research Areas:
Cat. No.: HY-P99457
CAS No.: 2148321-77-9
Synonyms: AGEN2034
Target:
Research Areas:
Cat. No.: HY-P99166
CAS No.: 2329669-72-7
Synonyms: XMAB-20717
Target:
Research Areas:
Cat. No.: HY-P99345
CAS No.: 2022215-59-2
Synonyms: TSR-042; ANB-011; WBP-285
Target:
Research Areas:
Cat. No.: HY-P99114
CAS No.: 2256084-03-2
Target:
Research Areas:
Cat. No.: HY-P99943
CAS No.: 2367013-69-0
Synonyms: KN-046
Target:
Research Areas:
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
